Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Nerve Damage After Administration of an Inferior Alveolar Nerve Block Using 4% Articaine Versus 2% Lidocaine

NCT06564987 is registered in ClinicalTrials.gov with Cleveland Dental Institute as lead sponsor.

NCT NCT06564987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06564987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Nerve Damage After Administration of an Inferior Alveolar Nerve Block Using 4% Articaine Versus 2% Lidocaine
Lead sponsor
Cleveland Dental Institute
Phase
Phase 1
Overall status
Unknown status
Start date
January 1, 2024
Completion date
March 31, 2025
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

inferior alveolar nerve injuries